News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,582 Results
Type
Article (18776)
Company Profile (122)
Press Release (213684)
Section
Business (72504)
Career Advice (949)
Deals (12650)
Drug Delivery (36)
Drug Development (29129)
Employer Resources (72)
FDA (3856)
Job Trends (4737)
News (118138)
Policy (8586)
Tag
2024 BioCapital Digital (3)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (548)
Accelerated approval (1)
Adcomms (13)
Allergies (22)
Alliances (21480)
ALS (36)
Alzheimer's disease (491)
Antibody-drug conjugate (ADC) (82)
Approvals (3848)
Artificial intelligence (107)
Autoimmune disease (9)
Automation (4)
Bankruptcy (88)
Best Places to Work (3230)
BIOSECURE Act (18)
Biosimilars (37)
Biotechnology (112)
Bladder cancer (28)
Brain cancer (14)
Breast cancer (93)
Cancer (909)
Cardiovascular disease (60)
Career advice (766)
Career pathing (20)
CAR-T (94)
Cell therapy (268)
Cervical cancer (7)
Clinical research (23548)
Collaboration (444)
Compensation (103)
Complete response letters (12)
COVID-19 (871)
CRISPR (17)
C-suite (137)
Cystic fibrosis (44)
Data (778)
Denatured (5)
Depression (20)
Diabetes (70)
Diagnostics (1529)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (21)
Drug discovery (69)
Drug pricing (23)
Drug shortages (2)
Duchenne muscular dystrophy (42)
Earnings (21702)
Editorial (17)
Employer branding (8)
Employer resources (69)
Events (36282)
Executive appointments (367)
FDA (4227)
Featured Employer (23)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (379)
Gene editing (51)
Generative AI (12)
Gene therapy (183)
GLP-1 (295)
Government (807)
Grass and pollen (1)
Guidances (13)
Healthcare (3279)
Huntington's disease (18)
IgA nephropathy (13)
Immunology and inflammation (65)
Indications (14)
Infectious disease (931)
Inflammatory bowel disease (81)
Inflation Reduction Act (3)
Influenza (25)
Intellectual property (50)
Interviews (139)
IPO (5278)
IRA (13)
Job creations (1646)
Job search strategy (708)
Kidney cancer (4)
Labor market (23)
Layoffs (171)
Leadership (11)
Legal (1998)
Liver cancer (26)
Lung cancer (120)
Lymphoma (59)
Machine learning (2)
Management (23)
Manufacturing (153)
MASH (23)
Medical device (1724)
Medtech (1726)
Mergers & acquisitions (7626)
Metabolic disorders (239)
Multiple sclerosis (32)
NASH (8)
Neurodegenerative disease (49)
Neuropsychiatric disorders (13)
Neuroscience (724)
NextGen: Class of 2025 (1577)
Non-profit (492)
Northern California (947)
Now hiring (17)
Obesity (131)
Opinion (175)
Ovarian cancer (43)
Pain (31)
Pancreatic cancer (28)
Parkinson's disease (59)
Partnered (9)
Patents (81)
Patient recruitment (31)
Peanut (13)
People (24885)
Pharmaceutical (16)
Phase I (8481)
Phase II (10844)
Phase III (6977)
Pipeline (478)
Podcasts (30)
Policy (55)
Postmarket research (515)
Preclinical (3379)
Press Release (62)
Prostate cancer (31)
Psychedelics (18)
Radiopharmaceuticals (98)
Rare diseases (188)
Real estate (2803)
Recruiting (36)
Regulatory (6448)
Reports (20)
Research institute (573)
Resumes & cover letters (152)
RNA editing (2)
RSV (13)
Schizophrenia (27)
Series A (86)
Series B (46)
Service/supplier (7)
Sickle cell disease (23)
Southern California (889)
Special edition (10)
Spinal muscular atrophy (52)
Sponsored (11)
Startups (2000)
State (1)
Stomach cancer (5)
Supply chain (25)
The Weekly (25)
United States (7976)
Vaccines (241)
Venture capitalists (33)
Webinars (9)
Weight loss (88)
Women's health (10)
Worklife (7)
Date
Today (4)
Last 7 days (257)
Last 30 days (1100)
Last 365 days (14022)
2025 (3314)
2024 (14557)
2023 (15625)
2022 (20796)
2021 (21192)
2020 (17477)
2019 (12314)
2018 (9651)
2017 (11545)
2016 (10441)
2015 (12294)
2014 (11984)
2013 (11227)
2012 (8141)
2011 (8531)
2010 (7797)
Location
Africa (376)
Alabama (27)
Alaska (3)
Arizona (48)
Arkansas (2)
Asia (28699)
Australia (4343)
California (2221)
Canada (781)
China (262)
Colorado (42)
Connecticut (93)
Delaware (38)
Europe (38230)
Florida (234)
Georgia (35)
Idaho (13)
Illinois (142)
India (16)
Indiana (105)
Iowa (3)
Japan (85)
Kansas (21)
Kentucky (4)
Louisiana (4)
Maine (4)
Maryland (363)
Massachusetts (1748)
Michigan (76)
Minnesota (139)
Missouri (18)
Montana (8)
Nebraska (5)
Nevada (9)
New Hampshire (7)
New Jersey (668)
New Mexico (11)
New York (600)
North Carolina (390)
North Dakota (4)
Northern California (947)
Ohio (56)
Oklahoma (7)
Oregon (9)
Pennsylvania (459)
Puerto Rico (3)
Rhode Island (8)
South America (478)
South Carolina (2)
Southern California (889)
Tennessee (19)
Texas (254)
Utah (40)
Virginia (35)
Washington D.C. (18)
Washington State (328)
Wisconsin (15)
232,582 Results for "sinovac biotech ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023.
April 29, 2024
·
26 min read
Press Releases
SINOVAC Issues Statement Regarding Privy Council Judgment
January 16, 2025
·
2 min read
Sinovac Amends Shareholder Rights Plan - February 21, 2024
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that its board of directors has amended its shareholder rights plan.
February 21, 2024
·
1 min read
Deals
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer - January 18, 2024
Sinovac Biotech Ltd. announced today that its Board of Directors (the “Board of Directors”) unanimously determined that the partial tender offer (the “Tender Offer”) by Alternative Liquidity Index LP (“Alternative Liquidity”).
January 18, 2024
·
9 min read
Press Releases
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
December 16, 2024
·
2 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Executive appointments
Women Leaders Decline in Biotech’s Era of ‘Proven Leadership’
Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a
BioSpace
analysis. This is happening in an era of biotech where new company founders are searching for CEOs with a track record.
February 5, 2025
·
8 min read
·
Annalee Armstrong
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
Sinovac Biotech Ltd. announced that its Board of Directors unanimously determined that the partial tender offer by Alternative Liquidity Index LP to acquire up to 10,000,000 common shares of Sinovac for $0.03 per share in cash is NOT advisable and is NOT in the best interests of the Company or its shareholders.
September 5, 2023
·
9 min read
SINOVAC Reports Unaudited First Half of 2023 Financial Results
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced its unaudited financial results for the six months ended June 30, 2023.
August 15, 2023
·
22 min read
C-suite
Biotech a Bright Spot for Female Founders Amid DEI Pullback
A new Pitchbook report found $4.3 billion in funding to women-fronted biotech companies across 121 deals. The increase comes as sociopolitical headwinds slam into initiatives to support women and minorities.
March 6, 2025
·
2 min read
·
Annalee Armstrong
1 of 23,259
Next
